Mancini et al., 2020 - Google Patents
The bladder EpiCheck test as a non-invasive tool based on the identification of DNA methylation in bladder cancer cells in the urine: a review of published evidenceMancini et al., 2020
View HTML- Document ID
- 8435188577806159024
- Author
- Mancini M
- Righetto M
- Zumerle S
- Montopoli M
- Zattoni F
- Publication year
- Publication venue
- International journal of molecular sciences
External Links
Snippet
Recently, there has been a great effort to develop tests based on non-invasive urinary biomarkers (NMIBCs). These tests are based on the fact that NMIBCs are heterogeneous at the molecular level and can be divided into different molecular groups useful to predict …
- 206010005003 Bladder cancer 0 title abstract description 50
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/28—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for programming tools or database systems, e.g. ontologies, heterogeneous data integration, data warehousing or computing architectures
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/24—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for machine learning, data mining or biostatistics, e.g. pattern finding, knowledge discovery, rule extraction, correlation, clustering or classification
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
- G06F17/30—Information retrieval; Database structures therefor; File system structures therefor
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/01—Social networking
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q10/00—Administration; Management
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06N—COMPUTER SYSTEMS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G06N99/00—Subject matter not provided for in other groups of this subclass
- G06N99/005—Learning machines, i.e. computer in which a programme is changed according to experience gained by the machine itself during a complete run
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mancini et al. | The bladder EpiCheck test as a non-invasive tool based on the identification of DNA methylation in bladder cancer cells in the urine: a review of published evidence | |
Maggi et al. | SelectMDx and multiparametric magnetic resonance imaging of the prostate for men undergoing primary prostate biopsy: a prospective assessment in a multi-institutional study | |
Ruffion et al. | PCA3 and PCA3-based nomograms improve diagnostic accuracy in patients undergoing first prostate biopsy | |
Divate et al. | Deep learning-based pan-cancer classification model reveals tissue-of-origin specific gene expression signatures | |
Modhukur et al. | Machine learning approaches to classify primary and metastatic cancers using tissue of origin-based DNA methylation profiles | |
Kalasauskas et al. | Identification of high-risk atypical meningiomas according to semantic and radiomic features | |
Kaushik et al. | A machine learning-based framework for the prediction of cervical cancer risk in women | |
Mazo et al. | Application of artificial intelligence techniques to predict risk of recurrence of breast cancer: a systematic review | |
Akbulut et al. | Prediction of perforated and nonperforated acute appendicitis using machine learning-based explainable artificial intelligence | |
Choi et al. | Atypical histiocytoid cells and multinucleated giant cells in fine-needle aspiration cytology of the thyroid predict lymph node metastasis of papillary thyroid carcinoma | |
Consiglio et al. | Explaining ovarian cancer gene expression profiles with fuzzy rules and genetic algorithms | |
Committeri et al. | Support tools in the differential diagnosis of salivary gland tumors through inflammatory biomarkers and radiomics metrics: a preliminary study | |
Morote et al. | Multiparametric magnetic resonance imaging grades the aggressiveness of prostate cancer | |
Di Pierro et al. | Comparison of four validated nomograms (memorial Sloan Kettering cancer center, briganti 2012, 2017, and 2019) predicting lymph node invasion in patients with high-risk prostate cancer candidates for radical prostatectomy and extended pelvic lymph node dissection: clinical experience and review of the literature | |
Allenet et al. | Can pre-operative neutrophil-to-lymphocyte ratio (NLR) help predict non-metastatic renal carcinoma recurrence after nephrectomy?(UroCCR-61 Study) | |
Pchejetski et al. | Circulating chromosome conformation signatures significantly enhance PSA positive predicting value and overall accuracy for prostate cancer detection | |
Rodrigo et al. | Thermal Liquid Biopsy (TLB): A predictive score derived from serum thermograms as a clinical tool for screening lung cancer patients | |
Gentile et al. | A neural network model combining [-2] proPSA, freePSA, total PSA, cathepsin D, and thrombospondin-1 showed increased accuracy in the identification of clinically significant prostate cancer | |
Liu et al. | A Systematic Review on Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA PET) Evaluating Localized Low-to Intermediate-Risk Prostate Cancer: A Tool to Improve Risk Stratification for Active Surveillance? | |
Pershad et al. | Using naïve bayesian analysis to determine imaging characteristics of KRAS mutations in metastatic colon cancer | |
Rummel et al. | Should genetic testing for cancer predisposition be standard-of-Care for women with invasive breast cancer? The murtha cancer center experience | |
Kang et al. | Lymph Node Ratio Predicts Recurrence in Patients with Papillary Thyroid Carcinoma with Low Lymph Node Yield | |
Ferriero et al. | The Impact of Metastasectomy on Survival Outcomes of Renal Cell Carcinoma: A 10-Year Single Center Experience | |
Morris et al. | Automated computational detection of disease activity in ANCA-associated glomerulonephritis using Raman spectroscopy: a pilot study | |
Grani et al. | Preoperative ultrasonography in the evaluation of suspected familial non-medullary thyroid cancer: are we able to predict multifocality and extrathyroidal extension? |